Dorman Products Q4 net sales up 25.9% to $501.3M; GAAP EPS $0.57; issues 2023 guidance

Dorman Products, Inc.

2022-FY EPS reported $3.85 revenue$1,733,749,000

Record Q4 net sales $501.3M (+25.9% YoY); FY2022 net sales $1.73B (+28.9%).
Q4 GAAP diluted EPS $0.57 (down from $1.07); adjusted diluted EPS $1.01 (down from $1.33).
FY2022 GAAP diluted EPS $3.85; adjusted diluted EPS $4.76 (up from $4.64).
2023 guidance: net sales $1.95B-$2.00B, GAAP EPS $4.35-$4.55, adjusted EPS $5.15-$5.35.
Acquisition of SuperATV completed Oct 2022; extra week in Q4 added ~$19M sales.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.98

Dorman Products, Inc. reported Fourth Quarter and Fiscal Year ended December 31, 2022 results: revenue net sales of $501.3 million for the quarter; fiscal 2022 net sales of $1,733.7 million, net income Net income for the fourth quarter of 2022 was $17.8 million; fiscal 2022 net income of $121.5 million, EPS diluted EPS of $0.57 for Q4; diluted EPS of $3.85 for fiscal 2022.

Period: Fourth Quarter and Fiscal Year ended December 31, 2022
Revenue: net sales of $501.3 million for the quarter; fiscal 2022 net sales of $1,733.7 million
Net income: Net income for the fourth quarter of 2022 was $17.8 million; fiscal 2022 net income of $121.5 million
EPS: diluted EPS of $0.57 for Q4; diluted EPS of $3.85 for fiscal 2022
Result: reported results

Exact text from the filing

Dorman Products, Inc. Reports Fourth Quarter and Fiscal 2022 Results and Issues 2023 Guidance

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

Dorman Products, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-23-005359

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.